Page last updated: 2024-08-23
epirubicin and aki603
epirubicin has been researched along with aki603 in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Hou, ZJ; Kamran, M; Lai, XJ; Lam, EW; Liu, JW; Liu, Q; Long, ZJ; Lu, G; Luo, Y; Shao, SJ; Wang, SW; Wang, X; Xia, JL; Xu, LZ; Yan, M; Zheng, FM | 1 |
Other Studies
1 other study(ies) available for epirubicin and aki603
| Article | Year |
|---|---|
A novel small molecule aurora kinase inhibitor attenuates breast tumor-initiating cells and overcomes drug resistance.
Topics: Animals; Antineoplastic Agents; Aurora Kinase A; Breast Neoplasms; Cell Cycle Checkpoints; Cell Proliferation; Drug Resistance, Neoplasm; Drug Synergism; Epirubicin; Female; Humans; MCF-7 Cells; Mice, Nude; Neoplastic Stem Cells; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Spheroids, Cellular; Tumor Burden; Xenograft Model Antitumor Assays | 2014 |